In human pregnancy, placental cytotrophoblasts that invade the uterus downregulate the expression of adhesion receptors that are characteristic of their epithelial origin, and upregulate the expression of adhesion receptors that are expressed by vascular cells. We suggest that this transformation could be critical to endovascular invasion, the process whereby cytotrophoblasts invade the uterine spiral arterioles and line their walls (Zhou et al. J. Clin. Invest. 1997. 99: 2139-2151.). To better understand the in vivo significance of these findings, we tested the hypothesis that in preeclampsia, an important disease of pregnancy in which endovascular invasion is abrogated, cytotrophoblasts fail to adopt a vascular adhesion phenotype. In experiments described here we stained placental bed biopsy specimens from age-matched control pregnancies and from those complicated by preeclampsia with antibodies that recognize adhesion molecules that are normally modulated during this transformation. In preeclampsia, differentiating/invading cytotrophoblasts fail to express properly many of these molecules, including integrin, cadherin, and Ig superfamily members. These results suggest that preeclampsia is associated with failure of cytotrophoblasts to mimic a vascular adhesion phenotype. The functional consequences of this abnormality are unknown, but are likely to affect negatively cytotrophoblast endovascular invasion and uterine arteriole remodeling, thereby compromising blood flow to the maternal-fetal interface.
Y Zhou, C H Damsky, S J Fisher
Title and authors | Publication | Year |
---|---|---|
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development
C Agostinis, R Bulla, C Tripodo, A Gismondi, H Stabile, F Bossi, C Guarnotta, C Garlanda, FD Seta, P Spessotto, A Santoni, B Ghebrehiwet, G Girardi, F Tedesco |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
The STOX1 genotype associated with pre-eclampsia leads to a reduction of trophoblast invasion by alpha-T-catenin upregulation
M Dijk, J Bezu, D Abel, C Dunk, MA Blankenstein, CB Oudejans, SJ Lye |
Human Molecular Genetics | 2010 |
Recent insights into the pathophysiology of preeclampsia
EM George, JP Granger |
Expert Review of Obstetrics & Gynecology | 2010 |
Pregnancy-Induced Hypertension and Preeclampsia: Levels of Angiogenic Factors in Malaysian Women
S Yelumalai, S Muniandy, SZ Omar, R Qvist |
Journal of Clinical Biochemistry and Nutrition | 2010 |
Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study
K Jeevaratnam, VD Nadarajah, JP Judson, S Nalliah, MF Abdullah |
BMC pregnancy and childbirth | 2010 |
AETIOLOGY AND PHYSIOPATHOLOGY OF PREECLAMPSIA AND RELATED FORMS
S Lorquet, C Pequeux, C Munaut, JM Foidart |
ACTA CLINICA BELGICA | 2010 |
Preeclampsia
SB Lee, AP Wong, K Kanasaki, Y Xu, VK Shenoy, TF McElrath, GM Whitesides, R Kalluri |
The American Journal of Pathology | 2010 |
Pathogenesis of Preeclampsia
BC Young, RJ Levine, SA Karumanchi |
Annual Review of Pathology: Mechanisms of Disease | 2010 |
Vascular Biology of the Placenta
Y Wang |
Colloquium Series on Integrated Systems Physiology: From Molecule to Function | 2010 |
Angiogenic proteins and adipocytokines as markers for prediction of preeclampsia
H Masuyama, Y Hiramatsu |
Expert Review of Obstetrics & Gynecology | 2010 |
An immunological insight into the origins of pre-eclampsia
E Laresgoiti-Servitje, N Gomez-Lopez, DM Olson |
Human Reproduction Update | 2010 |
Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia
T Cayci, EO Akgul, YG Kurt, I Aydin, H Alacam, E Ozkan, H Yaman, E Cakir, O Deren, P Dogan, C Bilgi, MK Erbil |
Clinical Chemistry and Laboratory Medicine | 2010 |
Risk of Pregnancy-Related Hypertension Within 5 Years of Exposure to Drinking Water Contaminated With Escherichia coli O157:H7
L Moist, JM Sontrop, AX Garg, WF Clark, RS Suri, R Gratton, M Salvadori, I Nevis, JJ Macnab |
The Journal of Clinical Hypertension | 2010 |
Ultrastructural and Immunofluorescence Studies of Placental Tissue in Hypertensive Diseases of Pregnancy
JP Judson, LP Fun, VD Nadarajah, S Nalliah, S Chakravart, P Thanikhaca, L Santhanara |
Research Journal of Biological Sciences | 2010 |
Effects of KRN633, an Inhibitor of Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase, on Vascular Development of Placenta and Fetus of Mid Pregnancy in Mice
Y Wada, H Ozaki, N Abe, T Nagamitsu, H Ohta, T Nakahara, K Ishii |
Journal of Pharmacological Sciences | 2010 |
Abnormal Placentation, Angiogenic Factors, and the Pathogenesis of Preeclampsia
M Silasi, B Cohen, SA Karumanchi, S Rana |
Obstetrics and Gynecology Clinics of North America | 2010 |
Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders
JE Cartwright, R Fraser, K Leslie, AE Wallace, JL James |
Reproduction | 2010 |
E-Cadherin, as a Negative Regulator of Invasive Behavior of Human Trophoblast Cells, Is Down-Regulated by Cyclosporin A Via Epidermal Growth Factor/Extracellular Signal-Regulated Protein Kinase Signaling Pathway1
HB Zhao, C Wang, RX Li, CL Tang, MQ Li, MR Du, XF Hou, DJ Li |
Biology of reproduction | 2010 |
Risk of pregnancy-related hypertension within 5 years of exposure to drinking water contaminated with Escherichia coli O157:H7.
Moist L, Sontrop JM, Garg AX, Clark WF, Suri RS, Gratton R, Salvadori M, Nevis I, Macnab JJ |
Journal of clinical hypertension (Greenwich, Conn.) | 2010 |